SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002729
Filing Date
2021-11-03
Accepted
2021-11-03 07:24:05
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kpti-20210930.htm   iXBRL 10-Q 2825353
2 EX-10.1 kpti-ex10_1.htm EX-10.1 14292
3 EX-31.1 kpti-ex31_1.htm EX-31.1 13046
4 EX-31.2 kpti-ex31_2.htm EX-31.2 13081
5 EX-32.1 kpti-ex32_1.htm EX-32.1 7926
6 EX-32.2 kpti-ex32_2.htm EX-32.2 8328
  Complete submission text file 0000950170-21-002729.txt   9602703

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20210930.xsd EX-101.SCH 61599
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kpti-20210930_lab.xml EX-101.LAB 527076
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20210930_def.xml EX-101.DEF 299349
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20210930_pre.xml EX-101.PRE 426367
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kpti-20210930_cal.xml EX-101.CAL 54068
12 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20210930_htm.xml XML 1718951
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 211373720
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences